Health Care & Life Sciences » Pharmaceuticals | Vital KSK Holdings Inc.

Vital KSK Holdings Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
564,655
548,012
621,040
581,117
565,587
559,718
Cost of Goods Sold (COGS) incl. D&A
522,936
506,453
572,031
536,478
521,809
515,226
Gross Income
41,719
41,559
49,009
44,639
43,778
44,492
SG&A Expense
38,515
39,742
42,055
41,430
41,394
41,670
EBIT
3,194
1,812
6,892
3,209
2,384
2,822
Unusual Expense
180
242
396
177
91
94
Non Operating Income/Expense
3,365
3,922
3,432
3,585
3,923
4,746
Interest Expense
42
88
43
42
46
73
Pretax Income
6,929
6,390
10,174
6,880
6,492
7,688
Income Tax
2,646
1,818
3,554
2,007
1,945
2,516
Consolidated Net Income
4,283
4,572
6,620
4,872
4,546
5,172
Net Income
4,235
4,527
6,556
4,778
4,467
5,085
Net Income After Extraordinaries
4,235
4,527
6,556
4,778
4,467
5,085
Net Income Available to Common
4,235
4,527
6,556
4,778
4,467
5,084
EPS (Basic)
71.95
79.49
117.24
84.78
79.26
90.21
Basic Shares Outstanding
59
57
56
56
56
56
EPS (Diluted)
71.95
73.56
100.97
73.00
68.23
77.64
Diluted Shares Outstanding
59
62
65
65
65
65
EBITDA
5,417
4,626
10,181
6,567
5,620
6,600
Other Operating Expense
10
5
62
-
-
-
Non-Operating Interest Income
156
150
145
139
142
149
Minority Interest Expense
48
45
64
94
79
87
Equity in Affiliates (Pretax)
76
836
144
168
180
139

About Vital KSK Holdings

View Profile
Address
Kyodo Building, 9/F
Tokyo Tokyo 103
Japan
Employees -
Website http://www.vitalksk.co.jp
Updated 07/08/2019
Vital KSK Holdings, Inc. engages in the management of its group companies which are involved in the pharmaceutical business. It operates through the Pharmaceutical Wholesale and Others segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners.